| 2024/04/24 22:00:00 | |
|---|---|
| Price | |
| 63.52 USD | |
| Difference | -0.27% (-0.17) |
General attributes
| ISIN | US09073M1045 |
| Symbol | TECH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 9,329 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 61.52 USD (100) |
| Ask (Ask size) | 63.52 USD (200) |
| Open | 63.22 USD |
| High | 63.945 USD |
| Low | 62.61 USD |
| Close (prev. day) | 63.69 USD |
| VWAP | 63.297182 USD |
| Volume (pcs) | 984,815 |
| Trading volume | 62,289,392.79 |
| Number of trades | 17,411 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: BIO-TECHNE CORP. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/24 22:00:00 | |
|---|---|
| Price | |
| 63.52 USD | |
| Difference | -0.27% (-0.17) |
General attributes
| ISIN | US09073M1045 |
| Symbol | TECH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 9,329 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 61.52 USD (100) |
| Ask (Ask size) | 63.52 USD (200) |
| Open | 63.22 USD |
| High | 63.945 USD |
| Low | 62.61 USD |
| Close (prev. day) | 63.69 USD |
| VWAP | 63.297182 USD |
| Volume (pcs) | 984,815 |
| Trading volume | 62,289,392.79 |
| Number of trades | 17,411 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -0.17% | -24.47% | -41.25% |
| Perf (abs.) | -0.11 | -20.58 | -44.60 |
| Beta | 1.36 | 0.99 | 1.15 |
| Volatility | 34.70 | 31.28 | 34.37 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 62.87 USD (1,023,162) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 68.11 USD (1,043,295) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 70.75 USD (1,084,373) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 73.22 USD (1,023,627) |
| YTD High | date | 78.75 USD (2024/03/08) |
| YTD Low | date | 61.16 USD (2024/04/18) |
| 52 Weeks High | date | 89.91 USD (2023/07/21) |
| 52 Weeks Low | date | 51.79 USD (2023/11/01) |
All listings for BIO-TECHNE CORP.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/24 | 22:26 | 59.50 EUR | 0.00 | 1 |
| Stuttgart | 2024/04/24 | 21:08 | 58.50 EUR | 0.00 | 7 |
| Nasdaq | 2024/04/24 | 22:00 | 63.52 USD | 62.29 | 17,411 |
| Munich | 2024/04/24 | 08:06 | 59.50 EUR | 0.00 | 2 |
| Frankfurt | 2024/04/24 | 21:50 | 59.00 EUR | 0.00 | 3 |
| Duesseldorf | 2024/04/24 | 08:11 | 59.00 EUR | 0.00 | 3 |
| Berlin | 2024/04/24 | 08:08 | 59.50 EUR | 0.00 | 2 |
Company Logo
Contact Details
| BIO-TECHNE CORP. |
| - - |
| 614 McKinley Place North East - 55413-2610 Minneapolis |
| Telefon: +1-612-379-8854 |
| Fax: +1-612-656-4400 |
| E-mail: info@bio-techne.com |
PDF Downloads
| Company report: BIO-TECHNE CORP. | |
Company Profile
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN. |
Members of Management Board
| Robert Baumgartner | Chairman of Board of Directors |
| Alpna Seth | Member of Board of Directors |
| Joseph Keegan | Member of Board of Directors |
| Randolph Steer | Member of Board of Directors |
| Roeland Nusse | Member of Board of Directors |
| Rupert Vessey | Member of Board of Directors |
| John Higgins | Member of Board of Directors |
| Julie Bushman | Member of Board of Directors |
| Charles Kummeth | Chairman of Managing Board |
| Brenda S. Everson | Member of Executive Committee |
| Jim Hippel | Member of Executive Committee |
| Kevin Smyth | Member of Executive Committee |